Tag: cancer research

Categories
Anti Cancer Cancer Research & Clinical Evidence Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Options Cancer Treatment Research & Critical Analysis Cancer Wellness Protocols Colorectal Cancer Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Hulscher Study Integrative Oncology Insights Ivermectin Mebendazole Natural Treatments Non-Chemo Cancer Treatments Pancreatic Cancer Repurposed Drug Studies Research News & Updates

What Oncologists and Evidence-Based Medicine Say About Ivermectin for Cancer Right Now

What science says about iveremctin and cancer

Courage Against Cancer clarifies that ivermectin lacks validated clinical evidence as a cancer treatment despite preclinical interest. Major oncology institutions do not endorse it, emphasizing the importance of rigorous evidence-based evaluations. Patients are encouraged to discuss concerns with their oncologists and critically assess claims surrounding off-label treatments.

Categories
Anti Cancer Breakthrough Therapies Cancer Research & Clinical Evidence Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment Claims & Critical Analysis Cancer Treatment Research & Critical Analysis Cancer Wellness Protocols Colorectal Cancer Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Gut Biome Gut-Microiome Health & Wellness Hulscher Study Integrative Oncology Insights Mebendazole Microbiome Non-Chemo Cancer Treatments Pancreatic Cancer Repurposed Drug Studies Research & Science Research News & Updates Wellness Company

What Is the Best Cancer Treatment for My Type and Stage of Cancer?

What Is the Best Cancer Treatment for My Type and Stage of Cancer

Courage Against Cancer emphasizes the importance of personalized cancer treatment plans, tailored based on cancer type, stage, and individual patient factors. This guide details various treatment modalities, including chemotherapy, radiation, immunotherapy, hormone therapy, and stem cell transplants, while encouraging patients to engage with their healthcare teams for informed decisions.

Categories
Anti Cancer cancer research Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Wellness Protocols Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Health & Wellness Hulscher Study Ivermectin Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Research News & Updates

Is The Wellness Company the only commercial seller of the compounded ivermectin-mebendazole product studied?

The Wellness Company (TWC) is the sole commercial seller of the ivermectin-mebendazole formulation studied in Hulscher et al. (2026), raising significant conflict-of-interest concerns. All authors are affiliated with TWC, skewing data reliability, especially as patient-reported benefits lack independent verification. Clinicians must provide guidance on evaluating such conflicts in cancer research.

Categories
Anti Cancer cancer research Coco the Koala Reports Community Impact Courage Foundation Projects Drug Repurposing & Innovation Foundation Updates Mission & Vision Nonprofit Innovation Research & Science Research Funding Research News & Updates

🌍 Five Dollars for the Forgotten: How Courage Against Cancer is Turning Compassion into a Cure

Coco the Koala celebrating your courage donating $5

Over 4,000 people downloaded Courage Against Cancer’s free guides last month. Now, one small $5 donation can help bring life-saving treatments closer to FDA approval — so one day, no child or family will be denied care because of cost.

Categories
Anti Cancer cancer research Cancer Treratments drug repurposing integrative-oncology Ivermectin Mebendazole Mission & Vision preclinical trial Repurposed Drug Studies Research & Science

The Synergy Puzzle: Could Ivermectin and Mebendazole Work With Standard Care?

Courage to launch a multi prong synergistic attack on cancer cells

The future of cancer treatment lies in combination. Discover the compelling science suggesting how repurposed drugs like ivermectin and mebendazole could work synergistically with standard therapies to improve outcomes and overcome treatment resistance.

Categories
Anti Cancer Breakthrough Therapies cancer research Coco the Koala Reports Courage Foundation Projects drug repurposing Drug Repurposing & Innovation Integrative Oncology Insights integrative-oncology Ivermectin MD Anderson Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Research News & Updates

Coco’s Big News: Courage Against Cancer Joins Forces with MD Anderson!

Coco the Koal is excited to be holding a Sponsored Research Agreement

G’day mates — it’s me, Coco the Koala, and I can hardly contain my excitement! Today’s a historic moment for our Courage Against Cancer family. 🧬

We’ve just submitted our very first Sponsored Research Agreement (SRA) to MD Anderson Cancer Center — one of the world’s leading institutions in cancer research. Together, we’re launching a preclinical trial studying ivermectin and mebendazole as potential treatments against ovarian cancer.

It’s the first courageous step toward FDA-approved, non-chemotherapy cancer therapies — and I’m beaming with hope! Stay tuned as we climb this new branch of discovery, one brave leaf at a time.

Stay Courageous, mates. Healing is possible.
— Coco the Koala 🐨

Categories
Anti Cancer cancer research Cancer Treratments Natural Treatments preclinical trial Repurposed Drug Studies

From Bench to Bedside: The Importance of Preclinical Trials in Developing Non-Conventional Cancer Therapies

Coco has the courage to lead the way to improved cancer patient care

Preclinical trials serve as a critical stepping stone in the journey from laboratory discovery to human application, especially in the realm of non-conventional cancer therapies. This article examines the significance of preclinical trials in the therapeutic development of promising drugs like Ivermectin and Mebendazole. By highlighting their current research landscape, we emphasize the undeniable importance of this phase in paving the way for groundbreaking cancer treatments.

Categories
Anti Cancer cancer research Cancer Treratments drug repurposing Ivermectin Mebendazole Mission & Vision preclinical trial Repurposed Drug Studies Research & Science

Breaking Barriers — The Future of Repurposed Drugs in Cancer Therapy

Coco the Koala has the courage to research repurposed drugs

Repurposing existing drugs like ivermectin and mebendazole offers a groundbreaking path forward in the war against cancer. Learn how Courage Against Cancer’s preclinical work on ovarian cancer may help establish the safety, mechanisms, and efficacy of these overlooked therapies — and how you can help us bridge science and compassion in the fight for human healing.

Categories
Anti Cancer cancer research Cancer Treratments drug repurposing integrative-oncology Mission & Vision preclinical trial Repurposed Drug Studies Research & Science

Beyond the Hype & The Headlines: Reclaiming the Conversation on Repurposed Drugs

Coco the Koala shows courage exploring new cancer treatments

In a landscape dominated by hype and headlines, our foundation is dedicated to a single, clear mission: moving the conversation about repurposed drugs like ivermectin and mebendazole from anecdote to evidence through rigorous, independent science.

Categories
Anti Cancer Cancer Treratments chemotherapy Fenbendazole Ivermectin Mebendazole Natural Treatments preclinical trial

A New Dawn: Courage Against Cancer Funds Its First Preclinical Trial on the Path to FDA Approval

Courage Against Cancer launches first preclinical trial of ivermectin and mebendazole against ovarian cancer

Courage Against Cancer announces a major milestone: funding our first preclinical trial for ivermectin and mebendazole. This is the critical first step on our rigorous path to achieve FDA approval and create a new, accessible paradigm in cancer therapy.